Drug Therapy for Phenylketonuria: Sapropterin Dihydrochloride
The most common treatment for phenylketonuria (PKU), which is a congenital genetic disorder, is diet therapy that limits the amount of protein and phenylalanine taken with foods. However, it is very difficult to comply with the diet, but as the age gets older, there are also problems with diet compliance. Because protein-restricted diet means that 80% of normal foods are completely prohibited.
The use of Sapropterin dihydrochloride, which is one of the treatment methods for patients with PKU, was approved by the American Food and Drug Administration (FDA) in 2007. In 2008, it started to be sold under license in Europe. In Turkey it can be purchased from pharmacies with a prescription since 2018.